WINTON GROUP Ltd purchased a new stake in shares of Bruker Corporation (NASDAQ:BRKR – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 79,750 shares of the medical research company’s stock, valued at approximately $3,757,000.
A number of other large investors also recently modified their holdings of the business. Parallel Advisors LLC increased its holdings in shares of Bruker by 121.0% during the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 479 shares during the period. CIBC Asset Management Inc acquired a new position in shares of Bruker during the fourth quarter valued at $203,000. Natixis Advisors LLC increased its holdings in shares of Bruker by 1.3% during the fourth quarter. Natixis Advisors LLC now owns 635,937 shares of the medical research company’s stock valued at $29,959,000 after purchasing an additional 8,265 shares during the period. BNP Paribas Financial Markets increased its holdings in shares of Bruker by 61.2% during the fourth quarter. BNP Paribas Financial Markets now owns 842,076 shares of the medical research company’s stock valued at $39,670,000 after purchasing an additional 319,726 shares during the period. Finally, Norges Bank acquired a new position in shares of Bruker during the fourth quarter valued at $3,773,000. 79.52% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on BRKR shares. Barclays raised their price target on Bruker from $45.00 to $53.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. UBS Group raised their price target on Bruker from $40.00 to $45.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Wall Street Zen raised Bruker from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Jefferies Financial Group set a $50.00 price target on Bruker in a report on Thursday, February 12th. Finally, Citigroup lifted their target price on Bruker from $40.00 to $44.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $50.54.
Insider Transactions at Bruker
In related news, VP Mark Munch sold 2,000 shares of Bruker stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $39.90, for a total transaction of $79,800.00. Following the transaction, the vice president directly owned 128,443 shares of the company’s stock, valued at $5,124,875.70. The trade was a 1.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 27.20% of the stock is currently owned by insiders.
Bruker Price Performance
NASDAQ:BRKR opened at $56.39 on Monday. The business’s 50-day moving average price is $42.57 and its 200 day moving average price is $43.46. The firm has a market cap of $8.58 billion, a P/E ratio of -234.96, a PEG ratio of 1.81 and a beta of 1.30. Bruker Corporation has a 52-week low of $28.53 and a 52-week high of $64.54. The company has a quick ratio of 0.72, a current ratio of 1.55 and a debt-to-equity ratio of 0.67.
Bruker (NASDAQ:BRKR – Get Free Report) last released its earnings results on Wednesday, May 6th. The medical research company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08. The firm had revenue of $823.40 million for the quarter, compared to analyst estimates of $795.62 million. Bruker had a positive return on equity of 11.60% and a negative net margin of 0.65%.Bruker’s revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.47 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, sell-side analysts predict that Bruker Corporation will post 2.12 earnings per share for the current fiscal year.
Bruker Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 7th. Investors of record on Monday, June 22nd will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, June 22nd. Bruker’s payout ratio is presently -83.33%.
Bruker Company Profile
Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.
Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.
In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.
Read More
- Five stocks we like better than Bruker
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR – Free Report).
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.
